Skip to content
HeyJared

Suraj Santlani

Reporter

Indexed articles, last 90 days
71
Latest publication
Oct 1, 2026
Outlet visibility, for yahoo.com
Top 1K sites
Earliest in this view
Sep 21, 2026

Latest articles

  1. Article · Oct 1, 2026 · Suraj Santlani

    What is Johnson & Johnson’s (JNJ) Economic Moat, and is it Widening or Narrowing? (opens the original)

    Excerpt · English

    Read excerpt

    Johnson & Johnson (NYSE:JNJ) closed at $264.74 on September 30, almost 43% higher than a year ago and within a few percent of its record. The company is worth about $638 billion and turns 29.19% of its $97.93 billion in revenue into operating profit. READ ALSO: Johnson & Johnson (JNJ) Taps Sail Biomedicines in Bid for CAR-T Edge Over Bristol Myers Squibb Individual drugs are not the asset. The ability to keep producing them is. Johnson & Johnson runs research, trials, approval, and global distri

  2. Article · Sep 30, 2026 · Suraj Santlani

    Is Best Buy’s (BBY) Moat Narrowing as Electronics Move Online for Good? (opens the original)

    Excerpt · English

    Read excerpt

    Best Buy Co., Inc. (NYSE:BBY) closed at $88.24 on September 30, up almost 17% over twelve months and close to its highest level in a year. The company is worth about $19 billion with a dividend yielding 4.35%. That is what the market pays for a business it expects to hold its position rather than grow. READ ALSO: Best Buy’s (BBY) Turnaround Gains Steam As Leadership Changes Hands Best Buy survived by turning its weakness into the thing competitors cannot copy. A national network of physical loca

  3. Article · Sep 30, 2026 · Suraj Santlani

    Synopsys (SNPS) vs Cadence (CDNS): Which is a Better Stock to Buy? (opens the original)

    Excerpt · English

    Read excerpt

    Synopsys, Inc. (NASDAQ:SNPS) and Cadence Design Systems, Inc. (NASDAQ:CDNS) between them supply almost all of the software used to design advanced chips. Both have fallen over the past twelve months even as the chips they help create have driven the market higher. That is the puzzle worth examining, because their share of the market has not visibly changed. READ ALSO: Synopsys (SNPS) Targets a 42% Non-GAAP Operating Margin. How Much Is the Ansys Acquisition Distorting Profitability? Synopsys is

  4. Article · Sep 30, 2026 · Suraj Santlani

    Goldman Sachs (GS) Board Discusses Naming John Waldron Chief Executive (opens the original)

    Excerpt · Neutral tone · English

    Read excerpt

    The Goldman Sachs Group, Inc. (NYSE:GS) may name chief operating officer John Waldron as its next chief executive as soon as next year, according to a Wall Street Journal report on September 28. He would succeed David Solomon. Waldron has been widely reported as the likely successor since becoming president and chief operating officer, so the news here is the timing rather than the name. READ ALSO: Citigroup (C) Lines Up a $3 Billion Banamex IPO for January Solomon would not be leaving under pre

  5. Article · Sep 30, 2026 · Suraj Santlani

    Robert Hunter Named UnitedHealth (UNH) Insurance President (opens the original)

    Excerpt · English

    Read excerpt

    UnitedHealth Group Incorporated (NYSE:UNH) is getting a new head of its insurance division, with executive Robert Hunter disclosing on September 28 that he will take the role. Hunter announced it himself in a post on LinkedIn, and the firm has issued no comments on the reasoning. The division he is taking over is the one whose margins broke. READ ALSO: UnitedHealth Partners with TPG to Strengthen Underperforming Florida Clinics UnitedHealthcare is the insurance arm, and it is where the medical c

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 1K sites

For yahoo.com, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

How this was measured

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Suraj Santlani